Yurong Lai serves as a Discipline Leader for drug transporter at Pfizer WRD. He received his M.D. degree from Fujian Medical University, Fujian, Fuzhou, China, and his Ph.D. degree in toxicology from Sapporo Medical University, Hokkaido, Sapporo, Japan, in 1998. From 1998 to 2001, he served as a Research Fellow at the Japan Society for the Promotion of Science (JSPS), Department of Physiopathology, Graduate School of Medicine, Hokkaido University, followed by a position as a Research Associate at the Department of Pharmaceutics, University of Washington. In 2004, Lai moved to PDM, PGRD St. Louis and then Groton in 2010, Pfizer Inc. and served as a PDM representative (PI) for preclinical project, Postdoc Supervisor, and Discipline Leader for drug transporter. His research interests and his group include discovery and development of drug candidates for the treatment of inflammation and pain, and drug transporter-related ADME/Tox, in particular hepatobiliary transporters. Lai's current research projects involve absolute differences of hepatobiliary transporters across species, structure-activity relationship and the evaluation of in vitro/in vivo models to scale up human PK prediction. He is a patent inventor and the author of over 80 research papers/book chapters.
Biography Updated on 28 November 2012